{
    "title": "Inovio lab tests show COVID vaccine weaker against Omicron, trial enrollment paused",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-10566619/Inovio-says-lab-tests-COVID-vaccine-weaker-against-Omicron.html",
    "date": "2022-03-01",
    "keywords": [
        "study",
        "trial",
        "vaccine",
        "inovio",
        "disease",
        "enrollment",
        "latestage",
        "omicron",
        "lab",
        "efficacy",
        "company",
        "goal",
        "prevention",
        "march",
        "inc",
        "covid19",
        "candidate",
        "shot",
        "variant",
        "ino4800",
        "tcell",
        "response",
        "design",
        "delay",
        "part",
        "line",
        "defense",
        "approval",
        "tuesday",
        "expectation",
        "vaccination",
        "nature",
        "market",
        "officer",
        "joseph",
        "call",
        "data",
        "safety",
        "board",
        "pause",
        "impact",
        "result",
        "half",
        "fda",
        "september",
        "hold",
        "information",
        "delivery",
        "device",
        "material",
        "partnership",
        "advaccine",
        "roy",
        "bengaluru",
        "editing",
        "syamnath"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}